Sponsored
released by
Evonik
08.16.23
Chemistry
Expert's Opinion
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Chemistry
Cytiva Introduces ELEVECTA Cell Lines
The three new cell lines meet the challenges and increasing demand of viral vector manufacturing.04.30.24
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Development | Formulation Development | Preclinical Outsourcing
Medincell, Abbvie Enter Development and Commercialization Pact
Medincell will provide formulation activities and preclinical studies, including supportive CMC work to advance candidates into trials.04.16.24
-
Breaking News | cGMP Manufacture | Chemistry
Sen-Jam Pharmaceutical Enters Strategic Partnership with KVK-Tech
KVK-Tech to provide formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam's injectable anti-inflammatory therapeutic.04.10.24
-
Analytical Services | Chemistry | Laboratory Testing
PAT, QbD, CM: 21st Century Manufacturing Paradigms
No matter, the chemistry is still the same.Emil W. Ciurczak, Contributing Writer 03.11.24
-
Breaking News | Chemistry | Industry News | Methods Development
Solvias to Perform Release Testing for Vertex's CASGEVY
Solvias invests significantly in preparing one of its global facilities to support the commercial release.01.24.24
-
Chemistry | Methods Development | Microbiology | Validation
-
Chemistry | Toxicology
-
Analytical Services | Chemistry | Drug Development | Laboratory Testing | Methods Development
-
Chemistry | Extractables and Leachables | Microbiology
-
Breaking News | Chemistry | Drug Development | Industry News
Samsung, Kurma Partner on Biologics for Kurma's Portfolio Companies
Samsung will provide customizable CMC development services for Kurma Partners.10.23.23
-
Bioanalytical Services | Breaking News | Chemistry | Drug Development | Drug Discovery | Industry News
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities
Expansion couples new biology services with existing chemistry capabilities.10.17.23
-
Breaking News | Chemistry | Drug Development | Industry News
Sterling Pharma Acquires NewChem Technologies
Adds further scientific resources and expertise to address complex process chemistry challenges.10.13.23
-
Breaking News | cGMP Manufacture | Chemistry | Clinical Trial Materials | Collaborations & Alliances | Drug Development | Formulation Development
Delnova, Pace Life Sciences Partner on ReViVox Development
Will support clinical development of DelNova’s lead candidate ReViVox to reverse unwanted paralysis induced by BoNTs such as Botox.10.05.23
-
Chemistry
-
APIs | Chemistry | Excipients
Evonik Health Care: A Leader in Sustainability
A Q&A with Eric Neuffer, Global Head of Drug Substance Sales, Evonik Health Care.
-
Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
GeneFab to Sublease Senti Biosciences cGMP Facility
GeneFab would also acquire Senti Bio’s CMC capabilities for approximately $38 million.08.14.23
-
APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Drug Discovery | Facilities | Industry News
Axplora Unveils New cGMP Pilot Facility for Flow Chemistry
Implementing flow chemistry at pilot scale enhances capabilities to develop safe, sustainable and efficient processes for customers.07.25.23
-
Chemistry | Drug Development | Formulation Development
Terran Biosciences, Pierre Fabre Ink Exclusive Licensing Deal for Idazoxan
Terran obtains exclusive global development and commercialization rights for idazoxan, a late-stage clinical therapeutic for schizophrenia06.02.23
-
Chemistry | Drug Development | Process Development | Scale-up/Technology Transfer
Early CMC Strategies to Support Late-Stage Success
Register now for our FREE webinar on July 19 to learn why a good strategy for early drug product CMC development is critical for commercial success.06.02.23
-
Breaking News | Chemistry | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News
PI Healthsciences Acquires Archimica S.p.A From Livia Group
Portfolio will include CRO, CDMO, and KSM/API solutions.05.05.23
